Catherine Stratton
About
Biography
Catherine is a second-year MPH student in Chronic Disease Epidemiology. In June 2018, she graduated from the University of Toronto where she studied public health and discovered her passion for pain medicine by assisting research on virtual reality ability to reduce patients’ anxiety. Catherine is particularly passionate about disability as a social determinant of health and how people with disabilities navigate ableist spaces and interactions. She co-founded the Implementation Science Group at Yale (ISG) where members discuss how best we can translate evidence into practice so that the newest health research findings can best serve various populations and their unique needs. She currently is a research associate at the Sports Equity Lab at Yale where she does research into the unique challenges faced by para-athletes.
Departments & Organizations
- Makhani Lab
Research
Publications
2020
Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
Rubinstein S, Lynch R, Desai A, Stratton C, Jha A, Bakouny Z, Schmidt A, Sica R, Bhutani D, Shah D, Wall S, Lyman G, Kuderer N, Weiss M, Warner J, Stockerl-Goldstein K, Mesa R, Thompson M. Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis. Blood 2020, 136: 28-30. PMCID: PMC8330211, DOI: 10.1182/blood-2020-141937.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSevere COVID-19COVID-19 outcomesSevere COVID-19 outcomesCOVID-19 diagnosisHematologic malignanciesCOVID-19 treatmentNational Cancer InstituteBristol-Myers SquibbPerformance statusClinical outcomesSupplemental oxygenICU levelMechanical ventilationPoor outcomeCytotoxic therapyCOVID-19Cancer InstituteEastern Cooperative Oncology Group performance statusLaboratory-confirmed COVID-19Cellular therapySars-Cov-2 infectionSevere COVID-19 illnessCytotoxic systemic therapyTherapy-related immunosuppressionPoor performance status